arBtrage CAPITALIZING MARKETS checking… Sign in

Upstream Bio, Inc.

UPB Health Care Biotechnology: Pharmaceutical Preparations
$7.05
▼ -5.1% Today
as of Jun 7, 07:30 ET
Last 30 days -25.87% Apr 28 → Jun 05
$6.85 $7.57 $8.28 $8.99 $9.71 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$7.39
High
$7.45
Low
$6.98
Volume
$661,750
Avg Vol
$702,852
Mkt Cap
$453M
P/E (TTM)
Beta
52w High
$33.68
52w Low
$6.98
Div Yield
Shares Out
$54M

Overview

52-week range
$6.98
$34
0% of range
Avg surprise (last 2)
+1.1%
Avg reaction (last 2)
-0.4%
50% positive
Latest IV / EM
512%
EM ±70.9% · $8 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-6.96$-5.34$-3.73$-2.11$-0.49 Actual $-2.11Actual $-4.68Actual $-6.50Actual $-6.96Actual $-0.51Est $-0.49Actual $-0.74Actual $-0.63Actual $-0.75Est $-0.80 SepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-41M$-30M$-20M$-9M$1M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.75 $-0.80 +6.2% -47.1% +4.6% earnings
Tue Sep 30, 2025Sep 2025 $-0.63 financials
Mon Jun 30, 2025Jun 2025 $-0.74 financials
Tue May 6, 2025Mar/2025 $-0.51 $-0.49 -4.1% -5.4% earnings
Mon Sep 30, 2024Sep 2024 $-6.96 financials
Sun Jun 30, 2024Jun 2024 $-6.50 financials
Sun Mar 31, 2024Mar 2024 $-4.68 financials
Sat Sep 30, 2023Sep 2023 $-2.11 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$1M$683,000$937,000$566,000$607,000$510,000
Cost of revenue
Gross profit
Operating income$-44M$-38M$-44M$-32M$-19M$-18M
Net income$-41M$-34M$-40M$-27M$-16M$-15M
EPS (diluted)$-0.75$-0.63$-0.74$-0.51$-6.96$-6.50

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$97M$102M$72M$45M$71M$326M$33M$47M
Inventory
Total current assets$316M$352M$389M$418M$454M$479M$227M
Total assets$318M$354M$391M$421M$456M$482M$233M
Long-term debt
Total liabilities$14M$14M$13M$12M$11M$12M$12M
Total equity$304M$340M$379M$409M$446M$470M$-160M$-147M

Implied volatility — last 90 days

507%509%512%514%517% Jun 07 — IV 512% · EM ±70.9%

Sector peers